Rituximab in Thrombotic Thrombocytopenic Purpura: Medical and Financial Benefits

Publisher： Karger

E-ISSN： 1421-9662|134|3|168-169

ISSN： 0001-5792

Source： Acta Haematologica, Vol.134, Iss.3, 2015-05, pp. : 168-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Thrombotic Thrombocytopenic Purpura and Gemcitabine

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura in Older Patients

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 36, Iss. 4, 1988-04 ,pp. : 331-338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelet transfusion in thrombotic thrombocytopenic purpura

By  

VOX SANGUINIS, Vol. 109, Iss. 2, 2015-08 ,pp. : 168-172

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine

By  

Acta Haematologica, Vol. 109, Iss. 1, 2002-12 ,pp. : 40-42

Karger

Access to resources Recommend Favorite

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-04 ,pp. : 196-199

Karger

Access to resources Recommend Favorite